Stocks
News
ETFs
Economy
Currencies
Press Releases
Articles from Fulcrum Therapeutics, Inc.; Slate Medicines
Fulcrum Therapeutics and Slate Medicines Announce Merger Agreement to Advance Next-Generation Migraine Therapies
Combined company to operate as Slate Medicines and focus on advancing Slate's portfolio of next-generation migraine therapeutics
By
Fulcrum Therapeutics, Inc.; Slate Medicines
· Via
GlobeNewswire
· August 17, 2026
Articles from Fulcrum Therapeutics, Inc.; Slate Medicines | Herald-Whig